|
|
Notice from the GRCA Health & Genetics Committee
...continued from Studies in Cancer
Dr. Ed Breitschwerdt is the principal investigator and Ashlee Duncan
is the graduate student responsible for the project.
The entry criteria for a case include: Golden Retrievers with a new
diagnosis of lymphoma that have not received any antibiotics within
14 days prior to sample collection (or 30 days for azithromycin).
Samples should be collected prior to induction of chemotherapeutic
agents.
The minimum entry criteria for a control include: Golden Retrievers
residing within 100 miles of the case dog and lacking clinical
evidence of lymphadenopathy, making the possibility of undetected
lymphoma unlikely. Additionally, these control dogs must not have
received any antibiotics within 14 days prior to sample collection
(or 30 days for azithromycin). For each case, two to three control
dogs will be utilized. If possible, these healthy dogs should be
similar in age (± 18 months) and sex as the case dog. Healthy dogs
may be identified by the owner of the case dog, selected by the
case's attending veterinarian, or recruited through the Golden
Retriever Club of America.
Cases and controls recruited will receive free serological and
molecular testing for Bartonella, Ehrlichia, and Anaplasma (a
$360.00 value based on current serology/PCR testing costs in our
laboratory). Samples to be collected for this research include whole
blood, serum, lymph node aspirate(s), and buccal swab(s).
Please contact us at 919-513-8279 or
awduncan@ncsu.edu for further
information.
Download documents:
The above documents require Adobe Acrobat
Reader to open and print. |
